2010, Volume 17, Supplement 3: PCI in the UK – the continuing journey
September 2010 Br J Cardiol 2010;17:s3-s4
PCI in the UK – the continuing journey
BJCardio staff
A new and exciting ‘journey’ in interventional cardiology began more than 20 years ago with the introduction of intracoronary stenting. ...
September 2010 Br J Cardiol 2010;17:s5-s8
Intervention: who to treat and how?
BJCardio staff
Treatment options in ACS include optimised medical therapy, intervention and surgical revascularisation. ...
September 2010 Br J Cardiol 2010;17:s9-s14
Optimising medical treatment of ACS
BJCardio staff
The first widely used antiplatelet agent, aspirin, continues to be standard therapy in ACS patients. The meta-analysis of the Antithrombotic Trialists’ Collaboration showed a 40% reduction in the rate of vascular events with aspirin.1...
